Clinical research sponsors face increasing pressure to design studies that balance therapeutic innovation, commercial expectations, and regulatory requirements. Misalignment among these drivers can result in operational inefficiencies, poor evidence generation, delayed decision-making, and risk of program failure.

This session explores practical approaches to strengthening governance and oversight frameworks that enhance the quality and predictability of study execution.

Attendees will gain insights on implementing early cross-functional governance strategies, designing quality-focused oversight frameworks, and fostering transparency and communication across sponsor stakeholders.

CEU: 1.0 ACRP

Speakers:

• Sara Garbin, Clinical Development Manager, Philips

• Sara Trbojevic, PhD, Clinical Development Scientist, Philips